Biotech startup Zymergen nabs $130 million from Softbank

Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes crazy new materials out of genetically alter microbes. It was busy buying up a bunch of robots to make these microbes for mass production of various materials during its last round of funding. CEO… Read More...